To confirm these results in a second human MM cell line and to validate that the stable knockdown of DSG2 had not caused some compensatory effects to overcome changes in cell signalling, we repeated these experiments in the DSG2+ RPMI8226 cells using a transient approach via small interfering RNA (siRNA). The gene discussed is DSG2; the disease is Miyoshi myopathy.